Newsbenzinga
RBC Capital Upgrades Pfizer to Sector Perform, Maintains Price Target to $25
· Published
Article summary
Please check the source for details.
An excerpt from the original article.Please check the source for details.
An excerpt from the original article.
Comments —
Loading comments…